The Impact of the Preprocessing Methods in Downstream Analysis of Agilent Microarray Data

Authors

  • Loredana BĂLĂCESCU The Oncology Institute “Prof. Dr. Ion Chiricuţă”, Department of Functional Genomics and Experimental Pathology, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania “Iuliu Haţieganu” University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, 23 Marinescu Street, 400337 Cluj-Napoca, Romania
  • Ovidiu BĂLĂCESCU The Oncology Institute “Prof Dr. Ion Chiricuta”, Cluj-Napoca, Romania.
  • Ioana BERINDAN-NEAGOE The Oncology Institute “Prof Dr. Ion Chiricuta”, Cluj-Napoca, Romania. University of Medicine and Pharmacy “I. Hatieganu”, Cluj-Napoca, Romania.

Keywords:

Microarray, Gene expression, Preprocessing, Agilent

Abstract

Over the past decades, gene expression microarrays have been used extensively in biomedical research. However, these high-throughput experiments are affected by technical variation and biases introduced at different levels, such as mRNA processing, labeling, hybridization, scanning and/or imaging. Therefore, data preprocessing is important to minimize these systematic errors in order to identify actual biological changes. The aim of this study was to compare all possible combinations of two normalization, four summarization, and two background correction options, using two different foreground estimates. The results shows that the background correction of the raw median signal and summarization methods used here have no impact in downstream analysis. In contrast, the choice of the normalization method influences the results; the quantile normalization leading to a better biological sensitivity of the data. When Agilent processed signal was considered, regardless of the summarization and normalization options, there were consistently identified more differentially expressed genes (DEG) than when raw median signal was used. Nevertheless, the greater number of DEG didn’t result in an improvement of the biological relevance.

Author Biographies

Loredana BĂLĂCESCU, The Oncology Institute “Prof. Dr. Ion Chiricuţă”, Department of Functional Genomics and Experimental Pathology, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania “Iuliu Haţieganu” University of Medicine and Pharmacy, Research Center for Functional Genomics, Biomedicine and Translational Medicine, 23 Marinescu Street, 400337 Cluj-Napoca, Romania

Department of Functional Genomics and Experimental Pathology

Research Center for Functional Genomics, Biomedicine and Translational Medicine

Ovidiu BĂLĂCESCU, The Oncology Institute “Prof Dr. Ion Chiricuta”, Cluj-Napoca, Romania.

Department of Functional Genomics and Experimental Pathology

Ioana BERINDAN-NEAGOE, The Oncology Institute “Prof Dr. Ion Chiricuta”, Cluj-Napoca, Romania. University of Medicine and Pharmacy “I. Hatieganu”, Cluj-Napoca, Romania.

Department of Functional Genomics and Experimental Pathology

Research Center for Functional Genomics, Biomedicine and Translational Medicine

Downloads

Additional Files

Published

15.09.2015

How to Cite

1.
BĂLĂCESCU L, BĂLĂCESCU O, BERINDAN-NEAGOE I. The Impact of the Preprocessing Methods in Downstream Analysis of Agilent Microarray Data. Appl Med Inform [Internet]. 2015 Sep. 15 [cited 2024 Dec. 25];37(4):29-37. Available from: https://ami.info.umfcluj.ro/index.php/AMI/article/view/553

Issue

Section

Articles